Picture of Refocus logo

RFCS Refocus Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Annual income statement for Refocus, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2000
December 31st
2001
December 31st
2002
December 31st
2003
December 31st
2004
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10KSB10KSB10KSB10KSB10KSB
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue1.310.23000
Cost of Revenue
Gross Profit0.7890.006000
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses3.794.843.085.63.69
Operating Profit-2.47-4.61-3.08-5.6-3.69
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-2.19-4.45-3.06-5.69-3.84
Provision for Income Taxes
Net Income After Taxes-2.19-4.45-3.06-5.69-3.84
Net Income Before Extraordinary Items
Net Income-2.19-4.45-3.06-5.69-3.84
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income-2.63-5.07-5.86-5.7-3.84
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.374-0.748-0.889-0.338-0.164
Dividends per Share